AAAlberto Alonso-Fernández

Alberto Alonso-Fernández

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alberto Alonso-Fernández has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Erosion of Critical Academic Skills Due to AI Dependency Among Tertiary Students

    by John Paul P. Miranda, Maria Anna D. Cruz, Antonia B. Fernandez, Francis F. Balahadia, Joey S. Aviles, Carisma A. Caro, Ivan G. Liwanag, Elizabeth P. Gaña

    This chapter investigates the perceived erosion of critical academic skills among 745 university students due to dependency on AI tools. The survey measured six key constructs: AI Dependency (AID), Cognitive Offloading (CO), Motivational Decline (MD), Academic Skills Erosion (ASE), Academic Integrity Awareness (AIA), and External Pressures (EP), using a five-point Likert scale. Path Analysis was employed to examine the interrelationships among these constructs. The results revealed a strong positive relationship between AID and both CO and MD, which indicated that the increased reliance on AI leads to reduced cognitive engagement and diminished academic motivation. Additionally, CO and MD were positively associated with ASE, which means that students who offload cognitive tasks and experience MD are more likely to exhibit deteriorating academic skills. While AIA had a weak negative relationship with AID, EP showed a moderate positive association and highlighted the role of academic stress in driving AI reliance.


  • Open Access

    Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients

    by Daniel Morell-Garcia, David Ramos-Chavarino, Josep M. Bauça, Paula Argente del Castillo, Maria Antonieta Ballesteros-Vizoso, Luis García de Guadiana-Romualdo, Cristina Gómez-Cobo, J. Albert Pou, Rocío Amezaga-Menéndez, Alberto Alonso-Fernández, et al.

    Risk factors associated with severity and mortality attributable to COVID-19 have been reported in different cohorts, highlighting the occurrence of acute kidney injury (AKI) in 25% of them. Among other, SARS-CoV-2 targets renal tubular cells and can cause acute renal damage. The aim of the present study was to evaluate the usefulness of urinary parameters in predicting intensive care unit (ICU) admission, mortality and development of AKI in hospitalized patients with COVID-19. Retrospective observational study, in a tertiary care hospital, between March 1st and April 19th, 2020. We recruited adult patients admitted consecutively and positive for SARS-CoV-2. Urinary and serum biomarkers were correlated with clinical outcomes (AKI, ICU admission, hospital discharge and in-hospital mortality) and evaluated using a logistic regression model and ROC curves. A total of 199 COVID-19 hospitalized patients were included. In AKI, the logistic regression model with a highest area under the curve (AUC) was reached by the combination of urine blood and previous chronic kidney disease, with an AUC of 0.676 (95%CI 0.512–0.840; p = 0.023); urine specific weight, sodium and albumin in serum, with an AUC of 0.837 (95% CI 0.766–0.909; p < 0.001) for ICU admission; and age, urine blood and lactate dehydrogenase levels in serum, with an AUC of 0.923 (95%CI 0.866–0.979; p < 0.001) for mortality prediction. For hospitalized patients with COVID-19, renal involvement and early alterations of urinary and serum parameters are useful as prognostic factors of AKI, the need for ICU admission and death.


  • Impaired circadian variation of platelet activity in patients with sleep apnea

    by Antonia Barceló, Javier Piérola, Mónica de la Peña, Guillem Frontera, Aina Yañez, Alberto Alonso-Fernández, Olga Ayllon, Alvar G. N. Agusti

    Cardiovascular diseases are frequent in patients with obstructive sleep apnea (OSAS). There is evidence that the day–night pattern of myocardial infarction and sudden cardiac death observed in the general population is altered in patients with OSAS. This study investigates potential abnormalities in the circadian profiles of platelet activity in OSAS. We studied 37 patients with OSAS [7 of whom were also studied after 3 months on continuous positive airway pressure (CPAP) treatment] and 11 controls. In each subject, we obtained six different blood samples during 24-h period (2200, 0200, 0600, 1000, 1400, and 1800 hours). Platelet activity was determined by flow cytometry immediately after sampling. We found that nocturnal platelet activity was significantly increased in patients with OSAS (p = 0.043) and that effective treatment with CPAP decreased platelet activity in these patients but differences just failed to reach statistical significance (p = 0.063). OSAS is associated with increased platelet activity during the night, and that this appears to be improved by chronic use of CPAP. These results may contribute to explain the high prevalence of cardiovascular events during sleep in OSAS.